As far as research subjects go, it's not always easy to find common ground with a single-celled bacterium. Yet the more Paul ...
UAB researchers are launching a space based study aboard the International Space Station to investigate how pneumonia causes ...
Fermeate, an industrial biotechnology company developing optogenetic control for industrial-scale precision fermentation, today announced a successful $2 million Seed round led by Newfund Capital with ...
Morning Overview on MSN
Hidden bacterial motor reveals a new target for drugs
A bacterium that thrives in warm coastal waters propels itself with a whip-like tail wrapped in a protective sleeve, and for ...
A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot ...
Fermeate uses optogenetics—precise control of gene expression with light—to turbocharge productivity in bioreactors, with ...
WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today ...
A new ACC scientific statement details the potential of gene editing for monogenic cardiovascular conditions like transthyretin amyloidosis.
Morning Overview on MSN
Sepsis target emerges as chloride channel PACC1 boosts bacteria killing
Every year, sepsis kills roughly 11 million people worldwide, more than lung cancer and heart attacks combined. Despite decades of research, no drug exists that directly strengthens the immune ...
A South African biotechnology collaboration has commercialised a key protein used to produce lab-grown meat. The development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results